Skip to main content
Skip to footer
About
Active Biotech in Brief
Management
Board of Directors
Goals and Strategy
Corporate Governance
Corporate Governance Report 2025
Article of Association
General Meetings
Audit committee
Scientific committee
Election Committee
Auditors
Projects
Our projects
Tasquinimod
Laquinimod
Naptumomab
Patents
Clinical Studies
Investor
Overview
Analyses and Presentations
Financial Calendar
Financial Reports
Shareholders
Events
Rights Issues
Rights Issue 2025
Media
Overview
Press Contact
Press Releases
Contact
Svenska
Events
Investor
Past events
2026
11
Jun
Active Biotech at EHA 2026
Stockholm
2026
21
Jan
Redeye Fight Cancer 2026
2025
06
Dec
American Society of Hematology (ASH) Annual meeting, Orlando, USA
Orlando, USA
2025
25
Nov
Aktiespararna: Stora Aktiedagarna, Stockholm
2024
07
Dec
66th American Society of Hematology Annual Meeting and Exposition – ASH 2024
2024
03
Dec
Redeye Technology & Life Science Day i Stockholm
2024
03
Jun
Bio International 2024
2024
30
May
Redeye Growth Day 2024
